Related references
Note: Only part of the references are listed.Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
Hamed Khalili et al.
BRITISH MEDICAL JOURNAL (2012)
Proton Pump Inhibitor Use and the Antifracture Efficacy of Alendronate
Bo Abrahamsen et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
S. Pouwels et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women Results From the Women's Health Initiative
Shelly L. Gray et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
Laura E. Targownik et al.
GASTROENTEROLOGY (2010)
Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
Douglas A. Corley et al.
GASTROENTEROLOGY (2010)
Inhibiting Gastric Acid Production Does Not Affect Intestinal Calcium Absorption in Young, Healthy Individuals: A Randomized, Crossover, Controlled Clinical Trial
Matthew J. Wright et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents
Mariko Teramura-Gronblad et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2010)
Proton Pump Inhibitors and Bone Fractures?
Loren Laine
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
Christian Roux et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Impaired gastric acidification negatively affects calcium homeostasis and bone mass
Thorsten Schinke et al.
NATURE MEDICINE (2009)
Another bad break for proton-pump inhibitors?
Laura E. Targownik
NATURE REVIEWS RHEUMATOLOGY (2009)
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Elaine W. Yu et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Hip fracture and proton pump inhibitor therapy: Position statement
Paul Moayyedi
CANADIAN JOURNAL OF GASTROENTEROLOGY (2008)
Use of proton pump inhibitors and risk of osteoporosisrelated fractures
Laura E. Targownik et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
American Gastroenterological Association institute technical review on the management of gastroesophageal reflux disease
P. J. Kahrilas et al.
GASTROENTEROLOGY (2008)
Proton pump-inhibiting drugs, calcium homeostasis, and bone health
Matthew J. Wright et al.
NUTRITION REVIEWS (2008)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture
P. Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Frailty: Emergence and consequences in women aged 65 and older in the women's health initiative observational study
NF Woods et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
MB O'Connell et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs
RJF Laheij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload - Role of gastric acid secretion
G Graziani et al.
NEPHRON (2002)
Share Paper
